Study: Deaths from most common lung cancer fall sharply as treatments advance
Incidence-based mortality for the most common U.S. lung cancer fell about 6% per year between 2013 and 2016 as treatment advances accelerated previous declines, according to a study reported this week in the New England Journal of Medicine.
“This analysis shows for the first time that nationwide mortality rates for the most common category of lung cancer, non-small cell lung cancer, are declining faster than its incidence, an advance that correlates with the U.S. Food and Drug Administration approval of several targeted therapies for this cancer in recent years,” said Douglas Lowy, M.D., National Cancer Institute deputy director and co-author of the study.
Related News Articles
Headline
The University of Utah Health shares how it is using intensive primary care to support patients navigating complex medical and social challenges. LISTEN NOW…
Headline
The Centers for Disease Control and Prevention announced today that there are now 1,487 confirmed measles cases nationwide so far this year. The CDC said 5% of…
Headline
Early-bird registration rates for the AHA’s Healthier Together Conference end March 31. This inaugural conference on community health…
Headline
“Hospitals are the heart of communities across America for one fundamental reason: They support patients whenever, wherever and however they need care,” writes…
Blog
I have the distinct privilege of serving as chair of the American Hospital Association’s Foster G. McGaw Prize Committee, which awards a prize each year to one…
Headline
Doug Brown, partner with Manatt Health and current chair of the AHA’s Foster G. McGaw Prize Committee, discusses how hospitals are tackling food insecurity,…